TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Isoniazid-rifapentine for latent TB infection: a systematic review and meta-analysis

A review published in the American Journal of Preventive Medicine examined the most recent evidence regarding 3-month isoniazid-rifapentine’s effectiveness, safety, and treatment completion when directly compared with other latent TB infection regimens primarily comprising 9-month isoniazid treatment.


Source: American Journal of Preventive Medicine

To subscribe to the Weekly Newsletter of new posts, enter your email here:


News

By Gibril J. Njie et al.

Published: June 22, 2018, 10:49 p.m.

Last updated: June 22, 2018, 10:51 p.m.

Print Share